Multimodal metabolic imaging of cerebral gliomas:: positron emission tomography with [18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
Multimodal metabolic imaging of cerebral gliomas:: positron emission tomography with [18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
复制标题
DOI:
10.3171/jns.2005.102.2.0318
复制
发表时间:
2005-02-01
影响因子:
4.1
通讯作者:
Sabel, M
中科院分区:
文献类型:
--
作者:
Floeth, FW;Pauleit, D;Sabel, M
Object. The purpose of this study was to determine the predictive value of [F-18]fluoroethyl-L-tyrosine (FET)-positron emission tomography (PET) and magnetic resonance (MR) spectroscopy for tumor diagnosis in patients with suspected gliomas.Methods. Both FET-PET and MR spectroscopy analyses were performed in 50 consecutive patients with newly diagnosed intracerebral lesions supposed to be diffuse gliomas on contrast-enhanced MR imaging. Lesion/brain ratios of FET uptake greater than 1.6 were considered positive, that is, indicative of tumor. Results of MR spectroscopy were considered positive when N-acetylaspartate (NAA) was decreased in conjunction with an absolute increase of choline (Cho) and an NAA/Cho ratio of 0.7 or less. An FET lesion/brain ratio, an NAA/Cho ratio, and signal abnormalities on MR images were compared with histological findings in neuronavigated biopsy specimens.Conclusions. In patients with intracerebral lesions supposed to be diffuse gliomas on MR imaging, FET-PET and MR spectroscopy analyses markedly improved the diagnostic efficacy of targeted biopsies.